lncRNA CERS6‐AS1 as ceRNA promote cell proliferation of breast cancer by sponging miR‐125a‐5p to upregulate BAP1 expression

Long noncoding RNAs (lncRNAs) can act as oncogene and tumor suppressor genes in many types of cancers including breast cancer (BC). Our previous study has indicated microRNA (miR)‐125a‐5p was downregulated and function as a tumor suppressor in BC. However, its upstream regulation mechanism is still...

Full description

Saved in:
Bibliographic Details
Published inMolecular carcinogenesis Vol. 59; no. 10; pp. 1199 - 1208
Main Authors Yan, Liang, Li, Kai, Feng, Zunyong, Zhang, Yizongheng, Han, Renrui, Ma, Jinzhu, Zhang, Jieling, Wu, Xu, Liu, Haijun, Jiang, Yuxin, Zhang, Yao, Zhu, Yiping
Format Journal Article
LanguageEnglish
Published United States Wiley Subscription Services, Inc 01.10.2020
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Long noncoding RNAs (lncRNAs) can act as oncogene and tumor suppressor genes in many types of cancers including breast cancer (BC). Our previous study has indicated microRNA (miR)‐125a‐5p was downregulated and function as a tumor suppressor in BC. However, its upstream regulation mechanism is still unclear. In this study, we used bioinformatics algorithms, RNA pulldown assay, and dual‐luciferase reports assay to predict and confirm lncRNA CERS6‐AS1 interacted with miR‐125a‐5p. Then we found CERS6‐AS1 was upregulated in BC tissues. Experimental results of tumor growth in nude mice show that CERS6‐AS1 promotes tumor growth. Furthermore, CERS6‐AS1 regulated BC susceptibility gene 1‐associated protein 1 (BAP1) expression via sponging miR‐125a‐5p via Western blot analysis and quantitative polymerase chain reaction arrays. Finally, we showed that miR‐125a‐5p had opposing effects to those of CERS6‐AS1 on BC cells, demonstrating that CERS6‐AS1 may promote cell proliferation and inhibit cell apoptosis via sponging miR‐125a‐5p. Our results indicated CERS6‐AS1 promote BC cell proliferation and inhibit cell apoptosis via sponging miR‐125a‐5p to upregulate BAP1 expression.
AbstractList Long noncoding RNAs (lncRNAs) can act as oncogene and tumor suppressor genes in many types of cancers including breast cancer (BC). Our previous study has indicated microRNA (miR)-125a-5p was downregulated and function as a tumor suppressor in BC. However, its upstream regulation mechanism is still unclear. In this study, we used bioinformatics algorithms, RNA pulldown assay, and dual-luciferase reports assay to predict and confirm lncRNA CERS6-AS1 interacted with miR-125a-5p. Then we found CERS6-AS1 was upregulated in BC tissues. Experimental results of tumor growth in nude mice show that CERS6-AS1 promotes tumor growth. Furthermore, CERS6-AS1 regulated BC susceptibility gene 1-associated protein 1 (BAP1) expression via sponging miR-125a-5p via Western blot analysis and quantitative polymerase chain reaction arrays. Finally, we showed that miR-125a-5p had opposing effects to those of CERS6-AS1 on BC cells, demonstrating that CERS6-AS1 may promote cell proliferation and inhibit cell apoptosis via sponging miR-125a-5p. Our results indicated CERS6-AS1 promote BC cell proliferation and inhibit cell apoptosis via sponging miR-125a-5p to upregulate BAP1 expression.Long noncoding RNAs (lncRNAs) can act as oncogene and tumor suppressor genes in many types of cancers including breast cancer (BC). Our previous study has indicated microRNA (miR)-125a-5p was downregulated and function as a tumor suppressor in BC. However, its upstream regulation mechanism is still unclear. In this study, we used bioinformatics algorithms, RNA pulldown assay, and dual-luciferase reports assay to predict and confirm lncRNA CERS6-AS1 interacted with miR-125a-5p. Then we found CERS6-AS1 was upregulated in BC tissues. Experimental results of tumor growth in nude mice show that CERS6-AS1 promotes tumor growth. Furthermore, CERS6-AS1 regulated BC susceptibility gene 1-associated protein 1 (BAP1) expression via sponging miR-125a-5p via Western blot analysis and quantitative polymerase chain reaction arrays. Finally, we showed that miR-125a-5p had opposing effects to those of CERS6-AS1 on BC cells, demonstrating that CERS6-AS1 may promote cell proliferation and inhibit cell apoptosis via sponging miR-125a-5p. Our results indicated CERS6-AS1 promote BC cell proliferation and inhibit cell apoptosis via sponging miR-125a-5p to upregulate BAP1 expression.
Long noncoding RNAs (lncRNAs) can act as oncogene and tumor suppressor genes in many types of cancers including breast cancer (BC). Our previous study has indicated microRNA (miR)‐125a‐5p was downregulated and function as a tumor suppressor in BC. However, its upstream regulation mechanism is still unclear. In this study, we used bioinformatics algorithms, RNA pulldown assay, and dual‐luciferase reports assay to predict and confirm lncRNA CERS6‐AS1 interacted with miR‐125a‐5p. Then we found CERS6‐AS1 was upregulated in BC tissues. Experimental results of tumor growth in nude mice show that CERS6‐AS1 promotes tumor growth. Furthermore, CERS6‐AS1 regulated BC susceptibility gene 1‐associated protein 1 (BAP1) expression via sponging miR‐125a‐5p via Western blot analysis and quantitative polymerase chain reaction arrays. Finally, we showed that miR‐125a‐5p had opposing effects to those of CERS6‐AS1 on BC cells, demonstrating that CERS6‐AS1 may promote cell proliferation and inhibit cell apoptosis via sponging miR‐125a‐5p. Our results indicated CERS6‐AS1 promote BC cell proliferation and inhibit cell apoptosis via sponging miR‐125a‐5p to upregulate BAP1 expression.
Author Li, Kai
Ma, Jinzhu
Feng, Zunyong
Liu, Haijun
Jiang, Yuxin
Zhang, Jieling
Wu, Xu
Yan, Liang
Zhu, Yiping
Zhang, Yizongheng
Zhang, Yao
Han, Renrui
Author_xml – sequence: 1
  givenname: Liang
  orcidid: 0000-0001-9066-8693
  surname: Yan
  fullname: Yan, Liang
  organization: Wannan Medical College
– sequence: 2
  givenname: Kai
  surname: Li
  fullname: Li, Kai
  organization: The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College)
– sequence: 3
  givenname: Zunyong
  surname: Feng
  fullname: Feng, Zunyong
  organization: Wannan Medical College
– sequence: 4
  givenname: Yizongheng
  surname: Zhang
  fullname: Zhang, Yizongheng
  organization: Southern Medical University
– sequence: 5
  givenname: Renrui
  surname: Han
  fullname: Han, Renrui
  organization: Wannan Medical College
– sequence: 6
  givenname: Jinzhu
  surname: Ma
  fullname: Ma, Jinzhu
  organization: Wannan Medical College
– sequence: 7
  givenname: Jieling
  surname: Zhang
  fullname: Zhang, Jieling
  organization: The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College)
– sequence: 8
  givenname: Xu
  surname: Wu
  fullname: Wu, Xu
  organization: Wannan Medical College
– sequence: 9
  givenname: Haijun
  surname: Liu
  fullname: Liu, Haijun
  organization: Wannan Medical College
– sequence: 10
  givenname: Yuxin
  orcidid: 0000-0002-1133-495X
  surname: Jiang
  fullname: Jiang, Yuxin
  email: jiangyx@wnmc.edu.cn
  organization: Wannan Medical College
– sequence: 11
  givenname: Yao
  surname: Zhang
  fullname: Zhang, Yao
  email: yaozhang@ahedu.gov.cn
  organization: Wannan Medical College
– sequence: 12
  givenname: Yiping
  surname: Zhu
  fullname: Zhu, Yiping
  email: zhuyiping@wnmc.edu.cn
  organization: The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College)
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32808708$$D View this record in MEDLINE/PubMed
BookMark eNp1kdtu1DAQhi1URLcFiSdAlrjhJsv4lNiXy6ocpHLQFq4jx3FWrhI72Ilg7-ANeEaeBKdbQKrg6teMvvntf-YMnfjgLUKPCawJAH0-mDVllKt7aEVAyYJWnJ-gFUilCqJkdYrOUroGIKQS8ACdMipBViBX6Hvvze7dBm8vdlflz28_NlcE64SNXZpjDEOYbK76fil619moJxc8Dh1uotVpwkZ7YyNuDjiNwe-d3-PB7bIVoUJnESOeAp7HaPdzr7Pbi80Hgu3X3EgpWz1E9zvdJ_voVs_Rp5cXH7evi8v3r95sN5eFYTzHEJRrA8SYqmOkkiBa25oma6PLBlqtKsV4SWxDrSRlyRiwlmkqFC-Bl5Sxc_Ts6JuDfJ5tmurBpSWZ9jbMqaacCSIl5ZDRp3fQ6zBHn3-3UKoEIUBk6sktNTeDbesxukHHQ_17uX9fNDGkFG33ByFQL3erB1Pf3C2j6zuocdPNpqeoXf-vgeI48MX19vBf4_rt9sj_Ak9KptM
CitedBy_id crossref_primary_10_1111_1759_7714_15035
crossref_primary_10_1186_s12957_021_02166_w
crossref_primary_10_1016_j_prp_2022_154245
crossref_primary_10_1080_21655979_2022_2059982
crossref_primary_10_1002_kjm2_12503
crossref_primary_10_1080_21655979_2021_2012620
crossref_primary_10_1002_jbt_23037
crossref_primary_10_1186_s12935_023_03121_3
crossref_primary_10_1016_j_scitotenv_2024_173041
crossref_primary_10_1097_CAD_0000000000001381
crossref_primary_10_3390_ijms24032107
crossref_primary_10_3724_abbs_2023226
crossref_primary_10_1155_2022_9292538
crossref_primary_10_2147_OTT_S278582
crossref_primary_10_1038_s41420_022_01150_x
crossref_primary_10_1038_s41375_024_02344_1
crossref_primary_10_1002_mc_23529
crossref_primary_10_1097_MPA_0000000000001806
crossref_primary_10_1038_s41419_021_03921_3
crossref_primary_10_1002_mc_23569
crossref_primary_10_1016_j_ncrna_2023_11_013
crossref_primary_10_2174_0929867329666220614091445
crossref_primary_10_1186_s12890_022_02272_9
Cites_doi 10.3390/ijms20153616
10.1093/nar/gkv1353
10.7150/ijbs.27197
10.1038/s41419-018-1170-0
10.1016/j.cell.2015.02.053
10.1007/s13258-019-00866-y
10.1371/journal.pone.0040169
10.1007/978-3-030-20301-6_4
10.3322/caac.21442
10.1158/0008-5472.CAN-16-0356
10.15252/embj.2018101110
10.1038/s41588-018-0252-3
10.1038/ncomms6383
10.1615/CritRevEukaryotGeneExpr.2017019494
10.1155/2015/439370
10.1136/jmg.2008.063123
10.1016/j.molcel.2017.09.015
10.1002/jcb.27124
10.1038/nature12986
10.2174/1871520616666160502122724
10.1098/rsob.160181
10.3389/fgene.2014.00249
10.1093/abbs/gmx047
10.1038/s41434-018-0026-7
10.1186/s12890-020-01180-0
10.1593/neo.09942
10.1038/nrg.2015.10
10.1186/s12943-017-0735-3
10.3322/caac.21492
10.1016/j.abb.2018.03.018
10.1038/onc.2017.184
10.1002/iub.2325
ContentType Journal Article
Copyright 2020 Wiley Periodicals LLC
2020 Wiley Periodicals LLC.
Copyright_xml – notice: 2020 Wiley Periodicals LLC
– notice: 2020 Wiley Periodicals LLC.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7TM
7TO
8FD
FR3
H94
P64
RC3
7X8
DOI 10.1002/mc.23249
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Nucleic Acids Abstracts
Oncogenes and Growth Factors Abstracts
Technology Research Database
Engineering Research Database
AIDS and Cancer Research Abstracts
Biotechnology and BioEngineering Abstracts
Genetics Abstracts
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Genetics Abstracts
Oncogenes and Growth Factors Abstracts
Technology Research Database
Nucleic Acids Abstracts
AIDS and Cancer Research Abstracts
Engineering Research Database
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

CrossRef
Genetics Abstracts
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
EISSN 1098-2744
EndPage 1208
ExternalDocumentID 32808708
10_1002_mc_23249
MC23249
Genre article
Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: Key Research Foundation of Wannan Medical College
  funderid: WK2019Z7
– fundername: Foundation of “Peak” Training Program for Scientific Research of Yijishan Hospital, Wannan Medical College
  funderid: GF2019G11
– fundername: Foundation for the Cultivation of Outstanding and Top Talents in Colleges and Universities of Anhui Province
  funderid: gxgnfx2019010
– fundername: National Natural Science Foundation of China
  funderid: 81802651; 81671586
GroupedDBID ---
.3N
.GA
.GJ
.Y3
05W
0R~
10A
123
1L6
1OB
1OC
1ZS
31~
33P
3SF
3WU
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAHQN
AAIPD
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABEFU
ABEML
ABIJN
ABJNI
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFO
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACRPL
ACSCC
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZMN
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFPM
AFGKR
AFPWT
AFRAH
AFWVQ
AFZJQ
AHBTC
AIACR
AIAGR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EBD
EBS
EJD
EMOBN
F00
F01
F04
F5P
FEDTE
FUBAC
G-S
G.N
GLUZI
GNP
GODZA
H.X
HBH
HF~
HGLYW
HHY
HHZ
HVGLF
HZ~
IH2
IX1
J0M
JPC
KBYEO
KQQ
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
M6P
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
NNB
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
QRW
R.K
RIWAO
RJQFR
ROL
RWI
RX1
RYL
SAMSI
SUPJJ
SV3
TEORI
TUS
UB1
V2E
V8K
W8V
W99
WBKPD
WHWMO
WIB
WIH
WIJ
WIK
WJL
WOHZO
WQJ
WRC
WUP
WVDHM
WWO
WXI
WXSBR
XG1
XPP
XV2
ZGI
ZXP
ZZTAW
~IA
~WT
AAYXX
AEYWJ
AGHNM
AGQPQ
AGYGG
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7TM
7TO
8FD
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
FR3
H94
P64
RC3
7X8
ID FETCH-LOGICAL-c3499-524ac01cc7f317805dedcb805ba6b0da9793461eb2e81663303d3a25946046233
IEDL.DBID DR2
ISSN 0899-1987
1098-2744
IngestDate Fri Jul 11 00:40:01 EDT 2025
Fri Jul 25 06:37:11 EDT 2025
Wed Feb 19 02:23:19 EST 2025
Thu Apr 24 23:00:37 EDT 2025
Tue Jul 01 00:38:47 EDT 2025
Wed Jan 22 16:34:36 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 10
Keywords breast cancer
lncRNA CERS6-AS1
miR-125a-5p
Language English
License 2020 Wiley Periodicals LLC.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3499-524ac01cc7f317805dedcb805ba6b0da9793461eb2e81663303d3a25946046233
Notes Liang Yan, Kai Li, and Zunyong Fen contributed equally to this work.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-1133-495X
0000-0001-9066-8693
PMID 32808708
PQID 2439605505
PQPubID 105347
PageCount 10
ParticipantIDs proquest_miscellaneous_2435188240
proquest_journals_2439605505
pubmed_primary_32808708
crossref_primary_10_1002_mc_23249
crossref_citationtrail_10_1002_mc_23249
wiley_primary_10_1002_mc_23249_MC23249
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate October 2020
2020-10-00
20201001
PublicationDateYYYYMMDD 2020-10-01
PublicationDate_xml – month: 10
  year: 2020
  text: October 2020
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Austin
PublicationTitle Molecular carcinogenesis
PublicationTitleAlternate Mol Carcinog
PublicationYear 2020
Publisher Wiley Subscription Services, Inc
Publisher_xml – name: Wiley Subscription Services, Inc
References 2015; 161
2009; 46
2018; 645
2020; 20
2017; 27
2017; 49
2017; 68
2016; 76
2019; 38
2016; 17
2018; 22
2018; 25
2018; 68
2009; 11
2016; 6
2018; 9
2014; 5
2014; 505
2019; 20
2019; 41
2017; 36
2017; 17
2018; 119
2020; 72
2017; 16
2015; 2015
2018; 50
2019; 1152
2012; 7
2018; 14
2016; 44
e_1_2_10_23_1
e_1_2_10_24_1
e_1_2_10_21_1
e_1_2_10_22_1
e_1_2_10_20_1
e_1_2_10_2_1
e_1_2_10_4_1
e_1_2_10_18_1
e_1_2_10_3_1
Hu HB (e_1_2_10_15_1) 2018; 22
e_1_2_10_19_1
e_1_2_10_6_1
e_1_2_10_16_1
e_1_2_10_5_1
e_1_2_10_17_1
e_1_2_10_8_1
e_1_2_10_14_1
e_1_2_10_7_1
e_1_2_10_12_1
e_1_2_10_9_1
e_1_2_10_13_1
e_1_2_10_34_1
e_1_2_10_10_1
e_1_2_10_33_1
e_1_2_10_11_1
e_1_2_10_32_1
e_1_2_10_31_1
e_1_2_10_30_1
e_1_2_10_29_1
e_1_2_10_27_1
e_1_2_10_28_1
e_1_2_10_25_1
e_1_2_10_26_1
37232354 - Mol Carcinog. 2023 May 26
References_xml – volume: 20
  start-page: 153
  issue: 1
  year: 2020
  article-title: LncRNA WTAPP1 promotes cancer cell invasion and migration in NSCLC by downregulating lncRNA HAND2‐AS1
  publication-title: BMC Pulm Med
– volume: 41
  start-page: 1431
  issue: 12
  year: 2019
  end-page: 1443
  article-title: A thiosemicarbazone derivative induces triple negative breast cancer cell apoptosis: possible role of miRNA‐125a‐5p and miRNA‐181a‐5p
  publication-title: Genes Genomics.
– volume: 1152
  start-page: 51
  year: 2019
  end-page: 64
  article-title: Breast cancer: current perspectives on the disease status
  publication-title: Adv Exp Med Biol
– volume: 44
  start-page: 3059
  issue: 7
  year: 2016
  end-page: 3069
  article-title: Linc‐RoR promotes c‐Myc expression through hnRNP I and AUF1
  publication-title: Nucleic Acids Res
– volume: 9
  start-page: 1158
  issue: 12
  year: 2018
  article-title: LncRNA UCA1 promotes tumor metastasis by inducing miR‐203/ZEB2 axis in gastric cancer
  publication-title: Cell Death Dis
– volume: 5
  start-page: 249
  year: 2014
  article-title: HumanViCe: host ceRNA network in virus infected cells in human
  publication-title: Front Genet
– volume: 50
  start-page: 1705
  issue: 12
  year: 2018
  end-page: 1715
  article-title: Long noncoding RNA MALAT1 suppresses breast cancer metastasis
  publication-title: Nat Genet
– volume: 22
  start-page: 1987
  issue: 7
  year: 2018
  end-page: 1993
  article-title: LncRNA LINC01116 competes with miR‐145 for the regulation of ESR1 expression in breast cancer
  publication-title: Eur Rev Med Pharmacol Sci
– volume: 68
  start-page: 394
  issue: 6
  year: 2018
  end-page: 424
  article-title: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
  publication-title: CA Cancer J Clin
– volume: 68
  start-page: 171
  issue: 1
  year: 2017
  end-page: 184.e6
  article-title: A peptide encoded by a putative lncRNA HOXB‐AS3 suppresses colon cancer growth
  publication-title: Mol Cell
– volume: 68
  start-page: 7
  issue: 1
  year: 2018
  end-page: 30
  article-title: Cancer statistics, 2018
  publication-title: CA Cancer J Clin
– volume: 17
  start-page: 47
  issue: 1
  year: 2016
  end-page: 62
  article-title: Unique features of long non‐coding RNA biogenesis and function
  publication-title: Nat Rev Genet
– volume: 25
  start-page: 321
  issue: 5
  year: 2018
  end-page: 330
  article-title: LncRNA FTX sponges miR‐215 and inhibits phosphorylation of vimentin for promoting colorectal cancer progression
  publication-title: Gene Ther
– volume: 5
  start-page: 5383
  year: 2014
  article-title: The oestrogen receptor alpha‐regulated lncRNA NEAT1 is a critical modulator of prostate cancer
  publication-title: Nat Commun
– volume: 17
  start-page: 152
  issue: 2
  year: 2017
  end-page: 163
  article-title: Breast cancer: current molecular therapeutic targets and new players
  publication-title: Anticancer Agents Med Chem
– volume: 119
  start-page: 8773
  issue: 11
  year: 2018
  end-page: 8783
  article-title: MiR‐125a‐5p functions as a tumour suppressor in breast cancer by downregulating BAP1
  publication-title: J Cell Biochem
– volume: 14
  start-page: 1715
  issue: 12
  year: 2018
  end-page: 1723
  article-title: TGF‐beta/SMAD4‐regulated LncRNA‐LINP1 inhibits epithelial‐mesenchymal transition in lung cancer
  publication-title: Int J Biol Sci
– volume: 161
  start-page: 790
  issue: 4
  year: 2015
  end-page: 802
  article-title: Endogenous tRNA‐derived fragments suppress breast cancer progression via YBX1 displacement
  publication-title: Cell
– volume: 36
  start-page: 5661
  issue: 41
  year: 2017
  end-page: 5667
  article-title: LncRNA‐mediated regulation of cell signaling in cancer
  publication-title: Oncogene
– volume: 46
  start-page: 358
  issue: 5
  year: 2009
  end-page: 360
  article-title: Germline mutation of microRNA‐125a is associated with breast cancer
  publication-title: J Med Genet
– volume: 76
  start-page: 6299
  issue: 21
  year: 2016
  end-page: 6310
  article-title: LncRNA HOXA11‐AS promotes proliferation and invasion of gastric cancer by scaffolding the chromatin modification factors PRC2, LSD1, and DNMT1
  publication-title: Cancer Res
– volume: 11
  start-page: 1208
  issue: 11
  year: 2009
  end-page: 1215
  article-title: The epidermal growth factor receptor responsive miR‐125a represses mesenchymal morphology in ovarian cancer cells
  publication-title: Neoplasia
– volume: 2015
  year: 2015
  article-title: Anaplastic thyroid carcinoma: a ceRNA analysis pointed to a crosstalk between SOX2, TP53, and microRNA biogenesis
  publication-title: Int J Endocrinol
– volume: 49
  start-page: 588
  issue: 7
  year: 2017
  end-page: 597
  article-title: LncRNA TUG1 influences papillary thyroid cancer cell proliferation, migration and EMT formation through targeting miR‐145
  publication-title: Acta Biochim Biophys Sin
– volume: 38
  issue: 17
  year: 2019
  article-title: LncRNA HAND2‐AS1 promotes liver cancer stem cell self‐renewal via BMP signaling
  publication-title: EMBO J
– volume: 72
  start-page: 1856
  issue: 9
  year: 2020
  end-page: 1869
  article-title: Role of microRNAs in infection: potential biomarkers and mechanism [published online ahead of print June 09, 2020]
  publication-title: IUBMB Life
– volume: 16
  start-page: 166
  issue: 1
  year: 2017
  article-title: LncRNA RP11‐436H11.5, functioning as a competitive endogenous RNA, upregulates BCL‐W expression by sponging miR‐335‐5p and promotes proliferation and invasion in renal cell carcinoma
  publication-title: Mol Cancer
– volume: 20
  start-page: 3616
  issue: 15
  year: 2019
  article-title: LncRNA NEAT1 silenced miR‐133b promotes migration and invasion of breast cancer cells
  publication-title: Int J Mol Sci
– volume: 6
  issue: 11
  year: 2016
  article-title: The miR‐125 family is an important regulator of the expression and maintenance of maternal effect genes during preimplantational embryo development
  publication-title: Open Biol
– volume: 27
  start-page: 197
  issue: 3
  year: 2017
  end-page: 204
  article-title: miRNA: a diagnostic and therapeutic tool for pancreatic cancer
  publication-title: Crit Rev Eukaryot Gene Expr
– volume: 645
  start-page: 117
  year: 2018
  end-page: 125
  article-title: Long non‐coding RNA ROR promotes radioresistance in hepatocelluar carcinoma cells by acting as a ceRNA for microRNA‐145 to regulate RAD18 expression
  publication-title: Arch Biochem Biophys
– volume: 505
  start-page: 344
  issue: 7483
  year: 2014
  end-page: 352
  article-title: The multilayered complexity of ceRNA crosstalk and competition
  publication-title: Nature
– volume: 7
  issue: 6
  year: 2012
  article-title: Ectopic expression of MiR‐125a inhibits the proliferation and metastasis of hepatocellular carcinoma by targeting MMP11 and VEGF
  publication-title: PLoS One
– ident: e_1_2_10_16_1
  doi: 10.3390/ijms20153616
– ident: e_1_2_10_29_1
  doi: 10.1093/nar/gkv1353
– ident: e_1_2_10_30_1
  doi: 10.7150/ijbs.27197
– ident: e_1_2_10_34_1
  doi: 10.1038/s41419-018-1170-0
– ident: e_1_2_10_21_1
  doi: 10.1016/j.cell.2015.02.053
– ident: e_1_2_10_8_1
  doi: 10.1007/s13258-019-00866-y
– ident: e_1_2_10_23_1
  doi: 10.1371/journal.pone.0040169
– ident: e_1_2_10_3_1
  doi: 10.1007/978-3-030-20301-6_4
– ident: e_1_2_10_4_1
  doi: 10.3322/caac.21442
– ident: e_1_2_10_19_1
  doi: 10.1158/0008-5472.CAN-16-0356
– ident: e_1_2_10_28_1
  doi: 10.15252/embj.2018101110
– ident: e_1_2_10_14_1
  doi: 10.1038/s41588-018-0252-3
– volume: 22
  start-page: 1987
  issue: 7
  year: 2018
  ident: e_1_2_10_15_1
  article-title: LncRNA LINC01116 competes with miR‐145 for the regulation of ESR1 expression in breast cancer
  publication-title: Eur Rev Med Pharmacol Sci
– ident: e_1_2_10_26_1
  doi: 10.1038/ncomms6383
– ident: e_1_2_10_6_1
  doi: 10.1615/CritRevEukaryotGeneExpr.2017019494
– ident: e_1_2_10_11_1
  doi: 10.1155/2015/439370
– ident: e_1_2_10_25_1
  doi: 10.1136/jmg.2008.063123
– ident: e_1_2_10_20_1
  doi: 10.1016/j.molcel.2017.09.015
– ident: e_1_2_10_9_1
  doi: 10.1002/jcb.27124
– ident: e_1_2_10_31_1
  doi: 10.1038/nature12986
– ident: e_1_2_10_5_1
  doi: 10.2174/1871520616666160502122724
– ident: e_1_2_10_22_1
  doi: 10.1098/rsob.160181
– ident: e_1_2_10_10_1
  doi: 10.3389/fgene.2014.00249
– ident: e_1_2_10_32_1
  doi: 10.1093/abbs/gmx047
– ident: e_1_2_10_33_1
  doi: 10.1038/s41434-018-0026-7
– ident: e_1_2_10_27_1
  doi: 10.1186/s12890-020-01180-0
– ident: e_1_2_10_24_1
  doi: 10.1593/neo.09942
– ident: e_1_2_10_12_1
  doi: 10.1038/nrg.2015.10
– ident: e_1_2_10_18_1
  doi: 10.1186/s12943-017-0735-3
– ident: e_1_2_10_2_1
  doi: 10.3322/caac.21492
– ident: e_1_2_10_17_1
  doi: 10.1016/j.abb.2018.03.018
– ident: e_1_2_10_13_1
  doi: 10.1038/onc.2017.184
– ident: e_1_2_10_7_1
  doi: 10.1002/iub.2325
– reference: 37232354 - Mol Carcinog. 2023 May 26;:
SSID ssj0011750
Score 2.414729
Snippet Long noncoding RNAs (lncRNAs) can act as oncogene and tumor suppressor genes in many types of cancers including breast cancer (BC). Our previous study has...
SourceID proquest
pubmed
crossref
wiley
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1199
SubjectTerms Animals
Apoptosis
Bioinformatics
Biomarkers, Tumor - genetics
Biomarkers, Tumor - metabolism
Breast cancer
Breast Neoplasms - genetics
Breast Neoplasms - metabolism
Breast Neoplasms - pathology
Cell growth
Cell Proliferation
Female
Gene Expression Regulation, Neoplastic
Humans
lncRNA CERS6‐AS1
Membrane Proteins - antagonists & inhibitors
Membrane Proteins - genetics
Mice
Mice, Nude
MicroRNAs - genetics
miRNA
miR‐125a‐5p
Oligonucleotides, Antisense - genetics
Polymerase chain reaction
RNA, Long Noncoding - genetics
Sphingosine N-Acyltransferase - antagonists & inhibitors
Sphingosine N-Acyltransferase - genetics
Tumor Cells, Cultured
Tumor suppressor genes
Tumor Suppressor Proteins - genetics
Tumor Suppressor Proteins - metabolism
Ubiquitin Thiolesterase - genetics
Ubiquitin Thiolesterase - metabolism
Xenograft Model Antitumor Assays
Title lncRNA CERS6‐AS1 as ceRNA promote cell proliferation of breast cancer by sponging miR‐125a‐5p to upregulate BAP1 expression
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fmc.23249
https://www.ncbi.nlm.nih.gov/pubmed/32808708
https://www.proquest.com/docview/2439605505
https://www.proquest.com/docview/2435188240
Volume 59
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3bSsNAEB1EUHzxfqk3VhB9St1m0zR9rEURoSJVQfAh7G62IrZpaVNQn_QP_Ea_xJnNRbyB-LSk3SbNZmb3zObMGYDdyBDuoIweXOwc9ETjSOMJxzMCwUbUQTuifOfWmX9y5Z1eV68zViXlwqT6EMWGG3mGna_JwaUaHXyIhvZ0mdAA5e4RVYvwULtQjiIBSru9guGEQ3F1rjvL3YP8h59Xom_w8jNatcvN8Rzc5H80ZZncl8eJKuunLxqO_7uTeZjNUChrpGazABMmXoSptC7l4yJMt7I37kvw0o11-6zBmkftC__t-bVxUWFyxLShDweWy2cY7f7TQZd4MvZRs36HKeK7J0yTXQ2ZemTExqWaSKx318ZTIeiR2FQHLOmz8WBobqmUmGGHjfMKMw8ZQzdehqvjo8vmiZOVbXC0wPgJQ1tPal7RutZBcBLwamQirbBV0lc8knWcEjy_giG9oZeWAhfRSEgMwzyfMmWFWIHJuB-bNWB1X7l-UMOxQcPhdS69qN7xFJeBEjUpeQn280cY6kzTnEprdMNUjdkNezq0Y1uCnaLnINXx-KHPZm4FYebJo9BFxIYhHwJFPEXxNfogDa2MTX9s-5CuHYKjEqym1lNcRLgBxzkxKMGetYFfrx62mrZd_2vHDZhxKfi3zMJNmEyGY7OFCClR29YX3gHhjgmf
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1fT9swED8x0ICXwRhsZTA8adqeUtw4TRPxVAqobLSaCkg8IEW24yJEm1YllYCn7RvsM_JJduf8QWxDQnuykjh2Yt_Zv7PPvwP4FBvCHXSiByc7BzXRONJ4wvGMQLAR91GO6Lxzp-u3T72vZ_WzGdgpzsJk_BDlghtphh2vScFpQXr7gTV0qKsEB8IXMEcBvYk4f69XckcRBaVdYEGDwiHLumCe5e528ebjuegvgPkYr9oJ52AJzotPzfxMrqrTVFX13R8sjv_5L8vwKgeirJlJzmuYMckKvMxCU96uwHwn33R_Az8Hie51m6y13zv273_8ah7XmLxm2tDNsXXnM4w2AOhiQK4ytrfZqM8UubynTJNoTZi6ZeSQS2GR2PCyh0Uh7pGY1McsHbHpeGIuKJqYYbvN7zVmbnIn3WQVTg_2T1ptJ4_c4GiBJhRat57UvKZ1o4_4JOD12MRaYaqkr3gsQxwVPL-GVr2hfUuB82gsJFpink-HZYVYg9lklJh3wEJfuX7QwLZB2eEhl14c9j3FZaBEQ0pegS9FH0Y6pzWn6BqDKCNkdqOhjmzbVuBjmXOcUXn8I89GIQZRrszXkYugDa0-xIpYRPkY1ZCaViZmNLV5iNoO8VEF3mbiU1Yi3IDjsBhU4LMVgidrjzotm64_N-MWLLRPOkfR0WH323tYdGktwDoabsBsOpmaTQRMqfpgFeM3dzQNuw
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bT9swFD5ioCFeYOOydbDNSNP2lJImbpo8ltKKAa1QAQlpD5HtOBNam0YllWBP8A_4jfwSznEuU3eR0J6sJI6d2OfY37GPvwPwKdKEO-hED052FmqitoTmrsW1i2AjilGO6Lxzf-AdXvCjy-Zl4VVJZ2FyfohqwY00w4zXpOBpFO_9Ig0dqzqhgeAFLHHPDihsw8Gwoo4iBkqzvoL2hEWGdUk8azt75ZvzU9Ef-HIerpr5prcG38ovzd1MftRnmayrn7-ROP7fr7yC1QKGsnYuN69hQSfr8DIPTHm7Dsv9Yst9A-5HiRoO2qzTHZ55j3cP7bMGE9dMabqZGmc-zWj5ny5G5Chj-ppNYibJ4T1jigRryuQtI3dcCorExldDLApRj8CkmbJswmbpVH-nWGKa7bdPG0zfFC66ySZc9LrnnUOriNtgKRcNKLRtuVB2Q6lWjOjEt5uRjpTEVApP2pEIcEzgXgNtek27li7OopEr0A7DfuQIx9wtWEwmiX4LLPCk4_ktbBuUHOxkwaMg5tIWvnRbQtg1-FJ2YagKUnOKrTEKczpmJxyr0LRtDXarnGlO5PGXPDulFISFKl-HDkI2tPkQKWIR1WNUQmpakejJzOQhYjtERzV4k0tPVYnr-DYOin4NPhsZ-GftYb9j0nfPzfgRlk8PeuHJ18HxNqw4tBBgvAx3YDGbzvR7REuZ_GDU4glBYQxq
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=lncRNA+CERS6-AS1+as+ceRNA+promote+cell+proliferation+of+breast+cancer+by+sponging+miR-125a-5p+to+upregulate+BAP1+expression&rft.jtitle=Molecular+carcinogenesis&rft.au=Yan%2C+Liang&rft.au=Li%2C+Kai&rft.au=Feng%2C+Zunyong&rft.au=Zhang%2C+Yizongheng&rft.date=2020-10-01&rft.issn=1098-2744&rft.eissn=1098-2744&rft.volume=59&rft.issue=10&rft.spage=1199&rft_id=info:doi/10.1002%2Fmc.23249&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0899-1987&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0899-1987&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0899-1987&client=summon